C-Jun N-terminal kinase inhibitors: Structural insight into kinase-inhibitor complexes

The activation of c-Jun N-terminal kinases (JNKs) plays an important role in physiological processes including neuronal function, immune activity, and development, and thus, JNKs have been a therapeutic target for various diseases such as neurodegenerative diseases, inflammation, and cancer. Efforts...

Full description

Bibliographic Details
Main Authors: Men Thi Hoai Duong, Joon-Hwa Lee, Hee-Chul Ahn
Format: Article
Language:English
Published: Elsevier 2020-01-01
Series:Computational and Structural Biotechnology Journal
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2001037020303020
id doaj-43e7cb1b698640da9d3a4027d3c6fbfa
record_format Article
spelling doaj-43e7cb1b698640da9d3a4027d3c6fbfa2021-01-02T05:08:42ZengElsevierComputational and Structural Biotechnology Journal2001-03702020-01-011814401457C-Jun N-terminal kinase inhibitors: Structural insight into kinase-inhibitor complexesMen Thi Hoai Duong0Joon-Hwa Lee1Hee-Chul Ahn2Department of Pharmacy, Dongguk University-Seoul, Goyang, Gyeonggi 10326, South KoreaDepartment of Chemistry and RINS, Gyeongsang National University, Jinju, Gyeongnam 52828, South Korea; Corresponding authors.Department of Pharmacy, Dongguk University-Seoul, Goyang, Gyeonggi 10326, South Korea; Corresponding authors.The activation of c-Jun N-terminal kinases (JNKs) plays an important role in physiological processes including neuronal function, immune activity, and development, and thus, JNKs have been a therapeutic target for various diseases such as neurodegenerative diseases, inflammation, and cancer. Efforts to develop JNK-specific inhibitors have been ongoing for several decades. In this process, the structures of JNK in complex with various inhibitors have contributed greatly to the design of novel compounds and to the elucidation of structure-activity relationships. Almost 100 JNK structures with various compounds have been determined. Here we summarize the information gained from these structures and classify the inhibitors into several groups based on the binding mode. These groups include inhibitors in the open conformation and closed conformation of the gatekeeper residue, non-ATP site binders, peptides, covalent inhibitors, and type II kinase inhibitors. Through this work, deep insight into the interaction of inhibitors with JNKs can be gained and this will be helpful for developing novel, potent, and selective inhibitors.http://www.sciencedirect.com/science/article/pii/S2001037020303020c-Jun N-terminal kinase (JNK)InhibitorComplex structureStructure-activity relationshipGatekeeper
collection DOAJ
language English
format Article
sources DOAJ
author Men Thi Hoai Duong
Joon-Hwa Lee
Hee-Chul Ahn
spellingShingle Men Thi Hoai Duong
Joon-Hwa Lee
Hee-Chul Ahn
C-Jun N-terminal kinase inhibitors: Structural insight into kinase-inhibitor complexes
Computational and Structural Biotechnology Journal
c-Jun N-terminal kinase (JNK)
Inhibitor
Complex structure
Structure-activity relationship
Gatekeeper
author_facet Men Thi Hoai Duong
Joon-Hwa Lee
Hee-Chul Ahn
author_sort Men Thi Hoai Duong
title C-Jun N-terminal kinase inhibitors: Structural insight into kinase-inhibitor complexes
title_short C-Jun N-terminal kinase inhibitors: Structural insight into kinase-inhibitor complexes
title_full C-Jun N-terminal kinase inhibitors: Structural insight into kinase-inhibitor complexes
title_fullStr C-Jun N-terminal kinase inhibitors: Structural insight into kinase-inhibitor complexes
title_full_unstemmed C-Jun N-terminal kinase inhibitors: Structural insight into kinase-inhibitor complexes
title_sort c-jun n-terminal kinase inhibitors: structural insight into kinase-inhibitor complexes
publisher Elsevier
series Computational and Structural Biotechnology Journal
issn 2001-0370
publishDate 2020-01-01
description The activation of c-Jun N-terminal kinases (JNKs) plays an important role in physiological processes including neuronal function, immune activity, and development, and thus, JNKs have been a therapeutic target for various diseases such as neurodegenerative diseases, inflammation, and cancer. Efforts to develop JNK-specific inhibitors have been ongoing for several decades. In this process, the structures of JNK in complex with various inhibitors have contributed greatly to the design of novel compounds and to the elucidation of structure-activity relationships. Almost 100 JNK structures with various compounds have been determined. Here we summarize the information gained from these structures and classify the inhibitors into several groups based on the binding mode. These groups include inhibitors in the open conformation and closed conformation of the gatekeeper residue, non-ATP site binders, peptides, covalent inhibitors, and type II kinase inhibitors. Through this work, deep insight into the interaction of inhibitors with JNKs can be gained and this will be helpful for developing novel, potent, and selective inhibitors.
topic c-Jun N-terminal kinase (JNK)
Inhibitor
Complex structure
Structure-activity relationship
Gatekeeper
url http://www.sciencedirect.com/science/article/pii/S2001037020303020
work_keys_str_mv AT menthihoaiduong cjunnterminalkinaseinhibitorsstructuralinsightintokinaseinhibitorcomplexes
AT joonhwalee cjunnterminalkinaseinhibitorsstructuralinsightintokinaseinhibitorcomplexes
AT heechulahn cjunnterminalkinaseinhibitorsstructuralinsightintokinaseinhibitorcomplexes
_version_ 1724359684682416128